Glycocolle

Quick links to important sections

Glycocolle

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glycocolle

What is Glycocolle?

Glycocolle is a medicinal solution consisting of glycine, a non-essential amino acid, dissolved in purified water. It is primarily used as an urological irrigating fluid during specific surgical procedures. Unlike many other medical solutions, glycocolle is non-conductive and transparent, which allows surgeons to maintain high visibility and use electrical surgical instruments safely within the body cavity.

Composition and Properties

The active ingredient in glycocolle is glycine (H2NCH2COOH). In a clinical context, it is prepared as a sterile, non-pyrogenic solution. Its primary physical properties include:

  • Non-Conductivity: Because glycine is a weak electrolyte, the solution does not conduct electricity. This is essential for procedures involving electrosurgery (such as diathermy).
  • Optical Clarity: The solution is clear and colorless, ensuring that the surgical field remains visible through endoscopic cameras.
  • Osmolarity: It is typically formulated to be hypotonic or near-isotonic to balance the need for clear visualization with the physiological requirements of the surrounding tissues.

Primary Uses

Glycocolle is utilized to wash out the bladder and urethral areas during surgery. Its most common application is during a Transurethral Resection of the Prostate (TURP) or similar endoscopic procedures involving the bladder.

During these operations, the solution serves two main purposes:

  1. Distension: It expands the surgical area (the bladder or prostatic urethra) to provide the surgeon with enough space to operate.
  2. Irrigation: It continuously flushes away blood, tissue fragments, and debris from the operative site, maintaining a clear view for the medical team.

How it Functions in the Body

When used as an irrigation fluid, glycocolle is intended to remain outside the vascular system. However, during surgery, some of the fluid may be absorbed into the bloodstream through opened veins. Once in the systemic circulation, glycine is metabolized primarily in the liver. It can be converted into several substances, including serine and glyoxylate, or eventually broken down into urea and exhaled as carbon dioxide.

Regulatory References

  1. FDA Drug Label Information

What side effects are possible with Glycocolle?

Possible Side Effects and Safety Information

The safety profile of Glycocolle (Glycine) is classified based on its preparation, separating effects from the oral supplement from those associated with the sterile irrigating solution used in surgery. The regulatory description of side effects varies significantly between these two uses.

Administration Route Primary Regulatory Focus
Oral Forms (Supplement) Generally mild gastrointestinal and central nervous system effects.
Irrigating Solution (Surgical) Serious fluid, electrolyte, and cardiovascular disturbances due to large-volume systemic absorption.

Side effects associated with the oral supplement are classified as Common and typically involve Gastrointestinal Disorders (such as nausea and abdominal discomfort) and Nervous System Disorders (such as headache, fatigue, and somnolence). These effects may be more noticeable at the beginning of treatment.

Regulatory documents highlight that the systemic absorption of the large volume of the irrigating solution during surgical procedures must be regarded as a systemic drug [3.3]. This absorption carries the risk of serious adverse reactions, which are classified as having a Frequency Not Known and affect critical systems:

  • Fluid and Electrolyte Disorders: Including severe Hyponatremia and Edema.
  • Vascular Disorders: Such as Hypotension and Cardiovascular Collapse.
  • Metabolism Disorders: Including Hyperammonemia, particularly in individuals with impaired liver function.

Official labeling mandates specific safety considerations for vulnerable populations. The irrigating solution is contraindicated in anuria (lack of urine production) and requires caution in patients with pre-existing cardiac, renal, or cardiopulmonary dysfunction due to the risk of extracellular fluid expansion and systemic consequences.

Overdose and Emergency Response

The official regulatory documentation for Glycocolle (Glycine) overdose primarily focuses on the systemic toxicity resulting from the massive absorption of the sterile nonelectrolytic irrigating solution. Overdose manifestations are linked to severe fluid and electrolyte imbalances, including pronounced hyponatremia, acidosis, and edema. Other documented presentations involve the central nervous system (CNS), such as confusion, convulsions, and transient blindness, as well as cardiopulmonary effects like hypotension, tachycardia, and pulmonary congestion.

The regulatory profile states that severe outcomes may include fulminating congestive heart failure related to rapid fluid expansion and coma or encephalopathy resulting from hyperammonemia, particularly in patients with impaired liver function. Because of these serious risks, official emergency response statements mandate immediate action: the user must discontinue the irrigant and contact a physician or a Poison Control Center right away. The official management involves instituting appropriate therapeutic countermeasures and intense fluid and electrolyte treatment to correct systemic imbalances. Caution is advised for patients with existing cardiac, renal, or hepatic dysfunction, as these conditions increase the risk of severe overdose complications.

Therapeutic Uses of Glycocolle

What Glycocolle Treats: Main Uses and Benefits

Glycocolle (Glycine) is generally applied in contexts where temporary assistance in symptom management and comfort is needed, often in conjunction with lifestyle factors. It is primarily used for its supportive therapeutic benefit across domains related to nervous system function and emotional well-being, given the compound's fundamental physiological relevance.

Glycocolle is commonly used to help manage symptoms related to psycho-emotional overload, sleep quality deficits, and cognitive strain. These include feelings of agitation, difficulty initiating sleep, poor concentration, and nervous system over-excitation. Applied in clinical settings that involve acute or unstable symptom patterns, Glycocolle offers symptomatic support and assists with maintaining functional stability.

This supportive relief contributes to improved day-to-day comfort during symptomatic periods. Glycocolle is relevant for easing symptoms that may be associated with conditions involving episodic or fluctuating manifestations, helping patients cope more steadily with difficult episodes.


Quick Facts: Therapeutic Support

Glycocolle is used in situations involving certain distressing symptoms, primarily supporting areas where additional symptomatic support is needed for managing tension and cognitive strain.

Eligibility and Restrictions for Use

Who Can and Cannot Use Glycocolle?

The population eligibility for Glycocolle (Glycine Irrigating Solution) is defined by official regulatory labeling, focusing on specific contraindications and patient conditions where use is restricted.

Contraindications and Restricted Use

Classification Population/Condition Regulatory Statement
Absolute Contraindication Patients with anuria (inability to pass urine) Must not be used in this population.
Use with Caution Severe cardiopulmonary dysfunction Careful monitoring is required.
Use with Caution Severe renal dysfunction Careful monitoring is required.
Use with Caution Known or suspected impaired liver function Caution should be exercised.

Age and Reproductive Status

  • Pediatric Patients: The safety and effectiveness of the solution have not been established in this age group, and its use is generally not recommended.
  • Geriatric Patients: Clinical studies did not include sufficient numbers of subjects aged 65 and over to definitively determine if they respond differently than younger adults.
  • Pregnancy: The medicine should be given to a pregnant woman only if clearly needed (Pregnancy Category C).
  • Lactation: Caution should be exercised when the solution is administered to a nursing mother.

Regulatory documents emphasize that the solution is intended only for its indicated surgical use and not for injection by usual parenteral routes.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Glycocolle (Glycine) 1.5% Irrigation USP identifies specific interaction-related cautions arising from the potential for systemic absorption during specialized surgical procedures. The interaction profile is not defined by enzyme inhibition or induction, but rather by the risk of physiological and metabolic disturbances.


Documented Interaction Cautions

Interaction Type Interacting Substance/Condition Regulatory Statement
Pharmacodynamic Risk Digitalis (Cardiac Glycosides) Documented risk of Digitalis toxicity specifically in patients who are digitalized. This risk relates to fluid and electrolyte changes following absorption.
Metabolic Caution Impaired Liver Function Risk of ammonia accumulation (hyperammonemia) in the blood due to reduced clearance of Glycine's metabolite in this patient population.

Official Regulatory Stance

No formal drug combinations are explicitly labeled as contraindicated in the official prescribing information based on an interaction mechanism. The primary interaction-related constraints are population-specific: caution is required when the product is administered to digitalized patients and those with impaired liver function. These statements define the essential structure of the drug's official interaction profile, focusing on conditions that increase the risk of toxicity or metabolic imbalance.

Mechanism of Action

Glycine's primary action is as a full agonist at the Glycine Receptor ( GlyR), a ligand-gated chloride channel in the spinal cord and brainstem. This binding facilitates rapid chloride ion influx, immediately hyperpolarizing the nerve cell and decreasing neuronal excitability. This core mechanism influences systems where receptor-specific modulation of rapid neural signaling occurs, modulating motor reflex pathways and nociceptive signaling pathways. It also acts as a necessary co-agonist at the NMDA receptor, contributing to the modulation of inhibitory and excitatory signaling dynamics.

The compound further modulates peripheral responses: activation of GlyR on non-neuronal cells leads to membrane hyperpolarization, suppressing Voltage-Operated Calcium Channels ( VOCs). This cascade limits calcium influx and reduces the release of inflammatory mediators and reactive oxygen species ( ROS), thereby influencing pathways related to tissue integrity. In its sterile solution form, the mechanism is physical: the solution is strictly nonelectrolytic, rendering it electrically non-conductive. This specialized property is required for the solution to be functionally non-conductive during high-frequency electrical procedures, resulting in the localization of electrical current through the biological medium.

Dosage and Administration Information

Official Administration Guidelines for Glycine (Glycocolle)

Glycine, also known as Glycocolle, is an amino acid. While the substance is widely available as a dietary supplement, a strictly regulated pharmaceutical formulation (1.5% Glycine Irrigation USP) is used in specific medical procedures. The administration guidelines below reflect standard clinical practices, reflecting approved uses and procedures.


Procedural Administration (Urologic Irrigation)

The 1.5% Glycine Irrigation USP solution is indicated for use exclusively as an irrigating fluid during transurethral surgical procedures, such as prostatic resection.

  • Route of Administration: Transurethral Instillation (Irrigation) only. It is NOT for injection by usual parenteral routes.
  • Preparation: The solution is supplied sterile and nonpyrogenic. It must be inspected visually for particulate matter or discoloration prior to use. Additives may be incompatible; consultation with a pharmacist is advised before mixing. Use aseptic technique when attaching the administration set.
  • Dosing and Administration: The total volume of solution used is solely at the discretion of the surgeon. The solution is administered via appropriate urologic instrumentation. To limit systemic absorption, the container height above the patient should generally not exceed 60 cm (approximately 2 feet).

Oral Use in Clinical Studies

For oral use, most clinical studies have investigated Glycine in the context of research or as a dietary supplement. Common oral dosing patterns for adults used in published research include:

Administration Scope Typical Dosing in Studies Timing and Frequency
General Supplementation 3 to 5 grams daily Usually taken once daily or split into smaller doses.
Sleep Quality 3 grams Taken approximately 30 minutes before bedtime.
Schizophrenia Adjuvant Doses ranging from 0.4 to 0.8 g/kg daily Often started low (e.g., 4 g daily) and increased gradually; taken in divided doses.

It is important to note that most oral glycine supplements are not approved as medications for specific diseases. Patients should consult a healthcare professional to determine appropriate use and dosage for any condition.

Recent Clinical Evidence

Research Evidence Overview: Studies for Glycocolle (Glycine)

Evidence for Use as a Sterile Surgical Irrigating Solution

The liquid, sterile form of Glycocolle (Glycine) was evaluated in research as a specialized surgical medium. The research base includes both long-standing post-marketing surveillance and observational studies, as well as Randomized Controlled Trials (RCTs) that compared the solution to other fluids used in surgical settings. Research examined the fluid's ability to act as a nonelectrolytic irrigant during specialized transurethral surgical procedures in adults, with documentation by authoritative regulatory evidence.

The research examined outcomes related to intraoperative and acute physiological parameters. Data show patterns related to the solution’s physical properties, which research describes as necessary for use alongside electrosurgical instruments. Studies monitored outcomes monitoring physiological strain or stress, such as Transurethral Resection (TUR) syndrome and temporary changes in blood chemistry.

Evidence from Trials for Subjective Sleep Quality and Fatigue

Research examined oral Glycocolle in trials assessing short-term or episodic symptom patterns, primarily focusing on subjective sleep quality and daytime fatigue. These studies were mostly short-term, double-blind, placebo-controlled Randomized Controlled Trials (RCTs), and they mainly included healthy adult volunteers with self-reported sleep complaints or individuals under partial sleep restriction.

In these studies, Glycocolle was evaluated in research exploring how symptoms change over time, using patient-reported outcomes describing perceived discomfort related to sleep. The trials reported patterns where participants assessed their sleep satisfaction and subjective daytime sleepiness. Findings describe patterns observed in the studies regarding these patient-reported metrics.

Evidence Quality, Consistency, and Areas of Uncertainty

Key limitations include that the sample sizes were modest in many of the core RCTs, and the evidence is limited to short follow-up durations. Long-term effects are not fully established. Furthermore, the reliance on patient-reported outcomes describing perceived discomfort means that findings help contextualize how patients reported their experience, but these subjective reports can differ from objective measurements. The research provides context but not individual predictions, but rather describes group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Glycocolle (FAQ)

Q: I've heard Glycocolle referred to as a 'booster' for other drugs—is that accurate?

Official regulatory documents describe the mechanism of Glycocolle (Glycine) as functioning as a necessary co-agonist at the NMDA receptor in the brain. This action contributes to the modulation of signals, influencing how the central nervous system manages inhibitory and excitatory responses. This mechanistic description is the basis for the idea that it may modify the effects of other substances.

Q: How does the body generally process or break down Glycocolle?

Regulatory information indicates that Glycine, like other amino acids, is metabolized by the body. Specifically, official warnings caution that reduced clearance of Glycine’s metabolite in individuals with impaired liver function can lead to a risk of ammonia accumulation (hyperammonemia). This suggests that the liver is involved in the process of breaking down and clearing the compound.

Q: Why is Glycocolle sometimes used for conditions other than its main approved purpose?

Glycocolle is primarily approved as a surgical irrigating solution, but its activity as an inhibitory neurotransmitter provides context for its broader research. As a co-agonist at the NMDA receptor, the compound has a known neurological role that supports the themes explored in research for conditions such as schizophrenia, even though this use is not part of its main regulatory approval.

Q: Is it common for people to experience temporary nausea when first starting Glycocolle?

According to the official product information for the oral supplement, side effects such as nausea and headache are listed as Common adverse events. These effects are stated to be more noticeable at the beginning of treatment, which can imply a temporary experience as the body adjusts.

Q: Is Glycocolle considered a controlled substance?

No. Official national regulatory lists indicate that Glycine, which is fundamentally an amino acid, is not classified as a controlled substance in the United States or comparable jurisdictions.

Q: How does Glycocolle affect driving or operating heavy machinery?

The official safety information for the oral supplement lists central nervous system effects such as somnolence (drowsiness) and fatigue as potential side effects. Official information states that activities requiring mental alertness, such as driving or operating heavy machinery, may be affected if these side effects occur.

Q: Does Glycocolle have a known risk of dependence or addiction?

The official prescribing information for the regulated product does not contain warnings regarding the potential for physical or psychological dependence or addiction to Glycine.

Q: What should I do if I suspect an allergic reaction to Glycocolle?

Regulatory information lists hypersensitivity reactions (allergic reactions) as a possible risk associated with Glycocolle use. Official sources typically recommend that the product be discontinued and that immediate professional medical evaluation be sought if a severe reaction is suspected.

Q: Is there a generic version of Glycocolle available?

Yes. The active compound, Glycine (Aminoacetic acid), is the generic name for the substance. The product, particularly the sterile irrigating solution, is manufactured and listed in regulatory databases by multiple generic suppliers.

Q: What happens if I accidentally take two doses of Glycocolle at once?

Standard regulatory guidelines indicate that in situations of accidental overdose, Poison Control Center contact or immediate medical attention is appropriate.

Q: Where can I find the official prescribing information sheet for Glycocolle?

Official prescribing information (Full Prescribing Information or USPI) is provided by government bodies and can be accessed through regulatory databases. These documents are typically found on national sites such as DailyMed (managed by the NIH) or the FDA drug label database.

Q: What happens if I take Glycocolle past its expiration date?

The expiration date reflects the time period during which the product is known to retain its strength, quality, and purity. This holds true only when the product is stored precisely according to its labeled conditions. Using a product past this date means its quality cannot be assured.

Q: Are there specific symptoms that warrant contacting a healthcare provider immediately while on Glycocolle?

Yes. The regulatory documentation for the surgical solution warns of the risk of serious adverse reactions linked to systemic absorption, including severe hyponatremia (low sodium levels) and hypotension (low blood pressure). These are examples of serious physical conditions that warrant immediate professional medical attention.

Q: Does the efficacy of Glycocolle change depending on the time of day it is taken?

While there is no general rule regarding efficacy, studies assessing the use of oral Glycocolle for sleep quality have used specific timing in their protocols. The research examined effects when the dose was taken approximately 30 minutes before bedtime to achieve the intended effect in those contexts.

Q: Is Glycocolle associated with any required lab monitoring (like blood tests)?

Yes, in certain circumstances. Due to the known risks associated with systemic absorption of the surgical solution, such as fluid and electrolyte imbalance and hyperammonemia in individuals with liver impairment, official warnings state that careful monitoring may be required in these specific patient populations.

How should Glycocolle be stored and disposed of?

The official regulatory requirements for storing and disposing of Glycocolle (Glycine) preparations are defined by the product's formulation, such as irrigation solutions or excipient-containing biologics.

Storage Requirements

Condition Regulatory Rule
Temperature Store Glycine Irrigation Solution at controlled room temperature (20 C to 25 C); Biologics must be stored below 25 C.
Freezing Do not freeze the solution or the biologic product.
Protection Keep Glycine-containing biologics in the outer carton to protect from light and avoid excessive heat for the irrigation solution.
Child Safety Store the product out of the sight and reach of children.

Stability and Disposal

The Glycine Irrigation Solution is for single-dose use only; the container and its unused portion must be discarded immediately after the procedure. Reconstituted Glycine-containing clotting factors have a strict stability limit and must be used within 3 hours. All unused medicinal product and waste material must be disposed of according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Glycocolle found in:

A-Z Index: